Dr Brent O'Carrigan
Dr O’Carrigan is a consultant medical oncologist specialising in melanoma and kidney cancer at Addenbrooke’s Hospital, Cambridge. He trained in Sydney and London, completing a fellowship in early phase oncology trials at the Royal Marsden Hospital and PhD in translational cancer research in immuno-oncology at the University of Cambridge.
He is PI for a broad portfolio of academic and commercial clinical trials including cellular therapy trials. He is regional chair of the Immunotherapy Toxicity Working group and Clinical Cancer Lead for the NHS Eastern Genomics Laboratory Hub (GLH).